Corvus Pharmaceuticals, Inc. (CRVS) Misses Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: CRVS) | Delayed: 10.45 -0.09 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.54 | 52 Week High | $17.77 | |||
| Open | $10.40 | 52 Week Low | $9.63 | |||
| Day High | $10.70 | P/E | N/A | |||
| Day Low | $10.29 | EPS | $0.00 | |||
| Volume | 281,287 | |||||
